JP2008521509A5 - - Google Patents

Download PDF

Info

Publication number
JP2008521509A5
JP2008521509A5 JP2007543585A JP2007543585A JP2008521509A5 JP 2008521509 A5 JP2008521509 A5 JP 2008521509A5 JP 2007543585 A JP2007543585 A JP 2007543585A JP 2007543585 A JP2007543585 A JP 2007543585A JP 2008521509 A5 JP2008521509 A5 JP 2008521509A5
Authority
JP
Japan
Prior art keywords
nitric oxide
patch further
component
patch
polyethyleneimine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007543585A
Other languages
English (en)
Other versions
JP5188184B2 (ja
JP2008521509A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/043051 external-priority patent/WO2006058318A2/en
Publication of JP2008521509A publication Critical patent/JP2008521509A/ja
Publication of JP2008521509A5 publication Critical patent/JP2008521509A5/ja
Application granted granted Critical
Publication of JP5188184B2 publication Critical patent/JP5188184B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Description

本発明の範囲内に含まれるその他の一酸化窒素放出剤には、限定されないが、例えば、ニトロ官能化化合物等の亜硝酸塩が含まれる。代表的な化合物には、ニトログリセリン、N−(エトキシカルボニル)−3−(4−モルホリニル)シドノンイミン、3−モルホリノシドノンイミン、1,2,3,4−オキサトリアゾリウム、5−アミノ−3−(3,4−ジ−クロロフェニル)−クロライド、1,2,3,4−オキサトリアゾリウム、5−アミノ−3−(クロロ−2−メチル−フェニル)クロライド、1,2,3,4−オキサトリアゾリウム、3−(3−クロロ−2−メチルフェニル)−5−[[[シアノメチルアミノ]カルボニル]アミノ]−水酸化物分子内塩(hydroxide inner salt)、S−ニトロソ−N−アセチル−(D,L)−ペニシラミン、1−[(4’,5’−ビス(カルボキシメトキシ)−2’−ニトロフェニル)メトキシ]−2−オキソ−3,3,ジエチル−1−トリアゼン二カリウム塩、[1−(4’,5’−ビス(カルボキシメトキシ)−2’−ニトロフェニル)メトキシ]−2−オキソ−3,3−ジエチル−1−トリアジンジアセトキシメチルエステルが含まれる。

Claims (10)

  1. 一酸化窒素誘導体部分を含むことができ、血流量を増加させる体の部分に接触した状態で配置することができる一酸化窒素送達パッチと、
    少なくとも1つの一酸化窒素誘導体部分と、
    前記装置の構成要素であるか、または、治療時に前記装置に添加される、活性化剤と、
    を含む、局所的一酸化窒素送達装置。
  2. 請求項1において、
    前記パッチが繊維材料をさらに含む、装置。
  3. 請求項1において、
    前記パッチがナノ繊維材料をさらに含む、装置。
  4. 請求項1において、
    前記パッチが一酸化窒素誘導体化材料をさらに含む、装置。
  5. 請求項1において、
    前記パッチがジアゼニウムジオラート材料をさらに含む、装置。
  6. 請求項1において、
    前記パッチが、直鎖ポリエチレンイミン、分岐ポリエチレンイミン、ポリエチレンイミンの共重合体、およびそれらの組み合わせから選ばれる一酸化窒素誘導体化ポリマーをさらに含む、装置。
  7. 請求項1において、
    前記パッチが、絆創膏、不織マット、織物マット、ガーゼ、および積層マットから選ばれる構成要素をさらに含む、装置。
  8. 請求項1において、
    前記パッチが患者に直接紡糸された繊維をさらに含む、装置。
  9. 請求項1において、
    前記活性化剤がアスコルビン酸、水、体液、リンパ液、胆汁、メタノール、エタノール、プロパノール、ブタノール、ペンタノール、ヘキサノール、フェノール、ナフトール、リン酸塩、コハク酸塩、炭酸塩、酢酸塩、ギ酸塩、プロピオン酸塩、酪酸塩、脂肪酸、およびアミノ酸から選ばれる、装置。
  10. 一酸化窒素放出成分と、
    活性化成分と、
    を含み、
    前記放出成分および前記活性化成分が、クリーム、ゲル、膏薬、軟膏(ointment)、香膏、ロウ膏、緩和薬、塗布薬、ローション、鎮痛剤、および軟膏(unguent)から選ばれる組成物を含む、局所的一酸化窒素送達組成物。
JP2007543585A 2004-11-29 2005-11-29 局所的一酸化窒素供給装置およびその治療的使用方法 Expired - Fee Related JP5188184B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63145404P 2004-11-29 2004-11-29
US60/631,454 2004-11-29
PCT/US2005/043051 WO2006058318A2 (en) 2004-11-29 2005-11-29 Topical nitric oxide donor devices

Publications (3)

Publication Number Publication Date
JP2008521509A JP2008521509A (ja) 2008-06-26
JP2008521509A5 true JP2008521509A5 (ja) 2008-10-30
JP5188184B2 JP5188184B2 (ja) 2013-04-24

Family

ID=36498619

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007543585A Expired - Fee Related JP5188184B2 (ja) 2004-11-29 2005-11-29 局所的一酸化窒素供給装置およびその治療的使用方法

Country Status (6)

Country Link
US (1) US20090214624A1 (ja)
EP (1) EP1827332A4 (ja)
JP (1) JP5188184B2 (ja)
CN (1) CN101065084A (ja)
CA (1) CA2588744A1 (ja)
WO (1) WO2006058318A2 (ja)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040018237A1 (en) * 2002-05-31 2004-01-29 Perricone Nicholas V. Topical drug delivery using phosphatidylcholine
DK1861130T3 (da) * 2005-02-11 2009-01-26 Nolabs Ab Anordning og fremgangsmåde til behandling af dermatomycosis og navnlig onychomycosis
EP1757278A1 (en) * 2005-08-23 2007-02-28 NOLabs AB Device, system, and method comprising microencapsulated liquid for release of nitric oxide from a polymer
EP3556401A1 (en) 2005-05-27 2019-10-23 The University of North Carolina at Chapel Hill Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications
MX2008002882A (es) 2005-09-07 2008-03-27 Tyco Healthcare Aposito de herida con deposito de vacio.
US20090112197A1 (en) * 2007-10-30 2009-04-30 Searete Llc Devices configured to facilitate release of nitric oxide
US20110190604A1 (en) * 2006-12-22 2011-08-04 Hyde Roderick A Nitric oxide sensors and systems
US20090110933A1 (en) * 2007-10-30 2009-04-30 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems and devices related to nitric oxide releasing materials
US8221690B2 (en) 2007-10-30 2012-07-17 The Invention Science Fund I, Llc Systems and devices that utilize photolyzable nitric oxide donors
US7862598B2 (en) * 2007-10-30 2011-01-04 The Invention Science Fund I, Llc Devices and systems that deliver nitric oxide
US8642093B2 (en) 2007-10-30 2014-02-04 The Invention Science Fund I, Llc Methods and systems for use of photolyzable nitric oxide donors
JP5172940B2 (ja) * 2007-03-27 2013-03-27 ノーラブズ エービー 一酸化窒素送達のための局所皮膚送達装置
US8980332B2 (en) 2007-10-30 2015-03-17 The Invention Science Fund I, Llc Methods and systems for use of photolyzable nitric oxide donors
US10080823B2 (en) 2007-10-30 2018-09-25 Gearbox Llc Substrates for nitric oxide releasing devices
US8349262B2 (en) 2007-10-30 2013-01-08 The Invention Science Fund I, Llc Nitric oxide permeable housings
US8877508B2 (en) 2007-10-30 2014-11-04 The Invention Science Fund I, Llc Devices and systems that deliver nitric oxide
US20090112193A1 (en) * 2007-10-30 2009-04-30 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems and devices that utilize photolyzable nitric oxide donors
US7897399B2 (en) * 2007-10-30 2011-03-01 The Invention Science Fund I, Llc Nitric oxide sensors and systems
US20090177133A1 (en) * 2008-01-04 2009-07-09 Kristine Kieswetter Reduced pressure dressing coated with biomolecules
CA2740135A1 (en) * 2008-10-30 2010-05-06 Chris Miller Wound dressings comprising a nitric oxide gas producing component and an oxygen releasing component
AU2010263098B2 (en) * 2009-06-22 2016-01-07 VERO Biotech LLC. Nitric oxide therapies
US9919072B2 (en) 2009-08-21 2018-03-20 Novan, Inc. Wound dressings, methods of using the same and methods of forming the same
WO2011022652A1 (en) 2009-08-21 2011-02-24 Novan, Inc. Topical gels
US9999702B2 (en) 2010-04-09 2018-06-19 Kci Licensing Inc. Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
EP2681286B1 (en) 2011-02-28 2018-08-15 Novan, Inc. Nitric oxide-releasing s-nitrosothiol-modified silica particles and methods of making the same
CN103547258B (zh) 2011-03-17 2017-10-20 特兰斯德梅尔生物工艺股份有限公司 局部一氧化氮系统及其使用方法
US8597264B2 (en) 2011-03-24 2013-12-03 Kci Licensing, Inc. Apparatuses, methods, and compositions for the treatment and prophylaxis of chronic wounds
WO2013130687A1 (en) 2012-03-01 2013-09-06 3M Innovative Properties Company Method of promoting wound healing
US8871262B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Compositions and methods for treatment of osteoporosis and other indications
US8871256B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and systems for treatment of inflammatory diseases with nitric oxide
US8871260B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Methods and compositions for muscular and neuromuscular diseases
US8871254B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Systems and methods for treatment of acne vulgaris and other conditions with a topical nitric oxide delivery system
US8871259B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Techniques and systems for treatment of neuropathic pain and other indications
US8871258B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment and prevention of learning and memory disorders
US8871261B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Cancer treatments and compositions for use thereof
US8871257B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Prevention and treatment of cardiovascular diseases using systems and methods for transdermal nitric oxide delivery
US8871255B2 (en) 2012-09-19 2014-10-28 Transdermal Biotechnology, Inc. Treatment of skin and soft tissue infection with nitric oxide
US9724419B2 (en) 2013-03-13 2017-08-08 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9387159B2 (en) 2013-03-13 2016-07-12 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9241899B2 (en) 2013-03-13 2016-01-26 Transdermal Biotechnology, Inc. Topical systems and methods for treating sexual dysfunction
US9849160B2 (en) 2013-03-13 2017-12-26 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US9295637B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Compositions and methods for affecting mood states
US9339457B2 (en) 2013-03-13 2016-05-17 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9295647B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US20140271937A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9295636B2 (en) 2013-03-13 2016-03-29 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
US9320758B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Brain and neural treatments comprising peptides and other compositions
US9314422B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Peptide systems and methods for metabolic conditions
US9314423B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Hair treatment systems and methods using peptides and other compositions
US9320706B2 (en) 2013-03-13 2016-04-26 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9687520B2 (en) 2013-03-13 2017-06-27 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9314417B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Treatment of skin, including aging skin, to improve appearance
US9393264B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Immune modulation using peptides and other compositions
US9314433B2 (en) 2013-03-13 2016-04-19 Transdermal Biotechnology, Inc. Methods and systems for treating or preventing cancer
US20140271938A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Systems and methods for delivery of peptides
US20140271731A1 (en) 2013-03-13 2014-09-18 Transdermal Biotechnology, Inc. Cardiovascular disease treatment and prevention
US9750787B2 (en) 2013-03-13 2017-09-05 Transdermal Biotechnology, Inc. Memory or learning improvement using peptide and other compositions
US9393265B2 (en) 2013-03-13 2016-07-19 Transdermal Biotechnology, Inc. Wound healing using topical systems and methods
EP2976095B1 (en) 2013-03-15 2020-12-23 3M Innovative Properties Company Wound healing compositions
CN105979969B (zh) * 2013-08-08 2020-09-11 诺万公司 局部用组合物和使用所述组合物的方法
MX351120B (es) 2013-11-07 2017-10-03 Bsn Medical Gmbh Apósito médico.
CN103965469B (zh) * 2014-04-25 2016-09-07 南京大学 液态外源性no供体及其制备和应用方法
EP3246050A1 (de) * 2016-05-17 2017-11-22 BSN medical GmbH Wund- oder hautauflage
WO2021068134A1 (zh) * 2019-10-09 2021-04-15 咏达生医材料股份有限公司 供给一氧化氮的多层装置
CA3172325A1 (en) 2020-04-02 2021-10-07 Maria ASPIOTI Wound dressing control and activation
GB202004868D0 (en) 2020-04-02 2020-05-20 Smith & Nephew Wound care compositions and methods of preparation thereof
CA3172240A1 (en) 2020-04-02 2021-10-07 Maria ASPIOTI Wound dressing
GB202114294D0 (en) 2021-10-06 2021-11-17 Smith & Nephew Wound dressing apparatuses and methods for nitric oxide delivery
GB202114307D0 (en) 2021-10-06 2021-11-17 Smith & Nephew Wound dressing compositions and methods of use and preparation therof
GB202114298D0 (en) * 2021-10-06 2021-11-17 Smith & Nephew Wound dressing with one or more composite layers

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6200558B1 (en) * 1993-09-14 2001-03-13 The United States Of America As Represented By The Department Of Health And Human Services Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
US5648101A (en) * 1994-11-14 1997-07-15 Tawashi; Rashad Drug delivery of nitric oxide
AU779991B2 (en) * 1999-08-10 2005-02-24 Board Of Regents, The University Of Texas System Method for increasing optic nerve, choroidal and retinal blood flow to facilitate the preservation of sight
US6737447B1 (en) * 1999-10-08 2004-05-18 The University Of Akron Nitric oxide-modified linear poly(ethylenimine) fibers and uses thereof
US6703046B2 (en) * 2001-10-04 2004-03-09 Medtronic Ave Inc. Highly cross-linked, extremely hydrophobic nitric oxide-releasing polymers and methods for their manufacture and use
US20030175333A1 (en) * 2002-03-06 2003-09-18 Adi Shefer Invisible patch for the controlled delivery of cosmetic, dermatological, and pharmaceutical active ingredients onto the skin
AU2003228460A1 (en) * 2002-04-04 2003-10-27 The University Of Akron Non-woven fiber assemblies
EP1497268A4 (en) * 2002-04-05 2006-01-18 Nitromed Inc NITROGEN OXIDE DISPENSER, COMPOSITIONS AND METHOD OF USE

Similar Documents

Publication Publication Date Title
JP2008521509A5 (ja)
JP5188184B2 (ja) 局所的一酸化窒素供給装置およびその治療的使用方法
JP6487039B2 (ja) スキンケア組成物の送達のためのデバイス
TW577760B (en) Transdermal patch with non-steroid antirheumatic agents having an acid group
US5098417A (en) Cellulosic wound dressing with an active agent ionically absorbed thereon
JP5346340B2 (ja) 創傷を治癒するため制御された酸化窒素放出を提供する超高分子ポリマー複合体
BR112016009986B1 (pt) emplastro médico e seu uso
JP2009514792A (ja) ポリマーから一酸化窒素を放出するための、マイクロカプセルに封入されたプロトンドナーを含む装置、システム、およびその製造方法
JP5469829B2 (ja) 殺菌消毒液および殺菌消毒剤
JP2012502715A5 (ja)
CN110446521A (zh) 配置用于一氧化氮的控制释放的医疗产品和方法
WO2001024839A1 (en) Silver-containing compositions, devices and methods for making
JP2008526746A (ja) 冷却局所用貼付製剤
JP2007521937A5 (ja)
ATE293998T1 (de) Entzündungshemmendes kissen
CN105228658B (zh) 一种药用敷料水凝胶复合织物及其制备方法和应用
JP2019531355A (ja) 2層局所治療システム
RU2616524C2 (ru) Пластырь с регулируемой окклюзией
Durmuş et al. Synthesis, characterization, and in vitro drug release properties of AuNPs/p (AETAC-co-VI)/Q nanocomposite hydrogels
AU3843000A (en) Percutaneous absorption preparations containing oxybutynin
US20240157018A1 (en) Deodorizer composition, absorbing body, and absorbent article
WO2007128985A2 (en) Skin dressing
RU2004100316A (ru) Пористый губчатый целлюлозный материал для лечения ран
JPH0533929B2 (ja)
JP2006232724A (ja) ゲル組成物及びその製造方法